
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach
Sandrine M. Caputo, Lisa Golmard, Mélanie Léoné, et al.
The American Journal of Human Genetics (2021) Vol. 108, Iss. 10, pp. 1907-1923
Open Access | Times Cited: 23
Sandrine M. Caputo, Lisa Golmard, Mélanie Léoné, et al.
The American Journal of Human Genetics (2021) Vol. 108, Iss. 10, pp. 1907-1923
Open Access | Times Cited: 23
Showing 23 citing articles:
Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing
Elaine Chen, Flavia M. Facio, Kerry Aradhya, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2339571-e2339571
Open Access | Times Cited: 94
Elaine Chen, Flavia M. Facio, Kerry Aradhya, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2339571-e2339571
Open Access | Times Cited: 94
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
Michael T. Parsons, Miguel de la Hoya, Marcy E. Richardson, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 9, pp. 2044-2058
Open Access | Times Cited: 17
Michael T. Parsons, Miguel de la Hoya, Marcy E. Richardson, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 9, pp. 2044-2058
Open Access | Times Cited: 17
The Challenge of Genetic Variants of Uncertain Clinical Significance
Wylie Burke, Erik Parens, Wendy K. Chung, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 994-1000
Open Access | Times Cited: 67
Wylie Burke, Erik Parens, Wendy K. Chung, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 994-1000
Open Access | Times Cited: 67
Ovarian cancer and its management through advanced drug delivery system
Sujit Bose, Shubham Sharma, Atul Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 1
Sujit Bose, Shubham Sharma, Atul Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 1
CHEK2 variants: linking functional impact to cancer risk
Rick A.C.M. Boonen, Maaike P.G. Vreeswijk, Haico van Attikum
Trends in cancer (2022) Vol. 8, Iss. 9, pp. 759-770
Closed Access | Times Cited: 30
Rick A.C.M. Boonen, Maaike P.G. Vreeswijk, Haico van Attikum
Trends in cancer (2022) Vol. 8, Iss. 9, pp. 759-770
Closed Access | Times Cited: 30
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
Özge Ceyhan-Birsoy, Gowtham Jayakumaran, Yelena Kemel, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Özge Ceyhan-Birsoy, Gowtham Jayakumaran, Yelena Kemel, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
Michael T. Parsons, Miguel de la Hoya, Marcy E. Richardson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Michael T. Parsons, Miguel de la Hoya, Marcy E. Richardson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Reclassification of VUS in BRCA1 and BRCA2 using the new “BRCA1/BRCA2 ENIGMA track set” demonstrates the superiority of ClinGen´s ENIGMA Expert Panel Specifications over the standard ACMG/AMP classification system
Anna Benet‐Pagès, Andreas Laner, Luis R Nassar, et al.
Genetics in Medicine Open (2025) Vol. 3, pp. 101961-101961
Open Access
Anna Benet‐Pagès, Andreas Laner, Luis R Nassar, et al.
Genetics in Medicine Open (2025) Vol. 3, pp. 101961-101961
Open Access
Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2
Raghad Al‐Jarf, Mengyuan Shen, Douglas E. V. Pires, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Raghad Al‐Jarf, Mengyuan Shen, Douglas E. V. Pires, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
A Comprehensive Evaluation of the Performance of Prediction Algorithms on Clinically Relevant Missense Variants
Erda Qorri, Bertalan Takács, Alexandra B. Graf, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7946-7946
Open Access | Times Cited: 10
Erda Qorri, Bertalan Takács, Alexandra B. Graf, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7946-7946
Open Access | Times Cited: 10
Principles of molecular testing for hereditary cancer
Chloe Mighton, Jordan Lerner‐Ellis
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 6, pp. 356-381
Closed Access | Times Cited: 9
Chloe Mighton, Jordan Lerner‐Ellis
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 6, pp. 356-381
Closed Access | Times Cited: 9
shinyseg: a web application for flexible cosegregation and sensitivity analysis
Christian Carrizosa, Dag E. Undlien, Magnus Dehli Vigeland
Bioinformatics (2024) Vol. 40, Iss. 5
Open Access | Times Cited: 1
Christian Carrizosa, Dag E. Undlien, Magnus Dehli Vigeland
Bioinformatics (2024) Vol. 40, Iss. 5
Open Access | Times Cited: 1
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management
Giovanni Innella, Cristina Fortuño, Laura Caleca, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Giovanni Innella, Cristina Fortuño, Laura Caleca, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort
Ahmed Bouras, Souhir Guidara, Mélanie Léoné, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3420-3420
Open Access | Times Cited: 3
Ahmed Bouras, Souhir Guidara, Mélanie Léoné, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3420-3420
Open Access | Times Cited: 3
Comprehensive clinical characterization of patients withBRCA1: c.5017_5019del germline variant
Yoon Ju Bang, Won Kyung Kwon, Jong‐Won Kim, et al.
Annals of Surgical Treatment and Research (2022) Vol. 103, Iss. 6, pp. 323-323
Open Access | Times Cited: 3
Yoon Ju Bang, Won Kyung Kwon, Jong‐Won Kim, et al.
Annals of Surgical Treatment and Research (2022) Vol. 103, Iss. 6, pp. 323-323
Open Access | Times Cited: 3
RNA Panel Sequencing Is an Effective Tool to Help Classify Splice Variants for Clinical Oncogenetic Diagnosis
Maud Privat, Flora Ponelle‐Chachuat, Sandrine Viala, et al.
Human Mutation (2024) Vol. 2024, pp. 1-14
Open Access
Maud Privat, Flora Ponelle‐Chachuat, Sandrine Viala, et al.
Human Mutation (2024) Vol. 2024, pp. 1-14
Open Access
Breast Cancer High-Penetrance Genes BRCA1 and BRCA2 Mutations Using Next-Generation Sequencing Among Iraqi Kurdish Women
Ahmad N Hassan, Mustafa S Mustafa
Cureus (2024)
Open Access
Ahmad N Hassan, Mustafa S Mustafa
Cureus (2024)
Open Access
Whole-exome sequencing and Drosophila modelling reveal mutated genes and pathways contributing to human ovarian failure
Ismael Henarejos-Castillo, F. Sanz, Cristina Solana‐Manrique, et al.
Reproductive Biology and Endocrinology (2024) Vol. 22, Iss. 1
Open Access
Ismael Henarejos-Castillo, F. Sanz, Cristina Solana‐Manrique, et al.
Reproductive Biology and Endocrinology (2024) Vol. 22, Iss. 1
Open Access
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes
Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 6, pp. 501-510
Closed Access | Times Cited: 1
Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 6, pp. 501-510
Closed Access | Times Cited: 1
Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance
Meryem Ozgencil, Julian Barwell, Marc Tischkowitz, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260852-e0260852
Open Access | Times Cited: 2
Meryem Ozgencil, Julian Barwell, Marc Tischkowitz, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260852-e0260852
Open Access | Times Cited: 2
Relação entre as mutações genéticas e a incidência do câncer de mama: revisão bibliográfica
Ana Flávia Queiroz Miquelanti, Bethânia Cristhine de Araújo, Natália de Fátima Gonçalves Amâncio
Research Society and Development (2023) Vol. 12, Iss. 1, pp. e2212139304-e2212139304
Open Access
Ana Flávia Queiroz Miquelanti, Bethânia Cristhine de Araújo, Natália de Fátima Gonçalves Amâncio
Research Society and Development (2023) Vol. 12, Iss. 1, pp. e2212139304-e2212139304
Open Access
Multiple synchronous malignancies in an infant with concomitant homozygous BRCA2 and PMS2 mutations with Fanconi anemia phenotype
Hamad Mohammed Alghanim, Mohamed Eltawel, Abdulmajeed Alhaidari, et al.
Pediatric Hematology and Oncology (2023) Vol. 40, Iss. 6, pp. 587-594
Closed Access
Hamad Mohammed Alghanim, Mohamed Eltawel, Abdulmajeed Alhaidari, et al.
Pediatric Hematology and Oncology (2023) Vol. 40, Iss. 6, pp. 587-594
Closed Access
The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination
Lucia Alvaro-Aranda, Ambre Petitalot, Yasmina Djeghmoum, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 12, pp. 6964-6976
Open Access
Lucia Alvaro-Aranda, Ambre Petitalot, Yasmina Djeghmoum, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 12, pp. 6964-6976
Open Access